| related words |
| bidil |
| antagonist |
| immunotherapy |
| antibody |
| rigorous |
| renal |
| melafind |
| glucose |
| interaction |
| soliris |
| surgeon |
| recothrom |
| feraheme |
| partnered |
| pinpoint |
| myvax |
| ipsen |
| novel |
| screening |
| biologics |
|
| related documents |
| 1020214--3/11/2010--CERUS_CORP |
| 1020214--2/26/2007--CERUS_CORP |
| 1020214--2/27/2006--CERUS_CORP |
| 1369140--8/16/2010--RainEarth_Inc. |
| 38264--12/16/2008--FORWARD_INDUSTRIES_INC |
| 1145197--3/9/2010--INSULET_CORP |
| 884909--3/12/2009--HOME_DIAGNOSTICS_INC |
| 810509--3/31/2008--NEOPROBE_CORP |
| 1145197--3/20/2008--INSULET_CORP |
| 881890--6/14/2010--ABAXIS_INC |
| 1138412--2/12/2008--GENOPTIX_INC |
| 820237--2/25/2008--GEN_PROBE_INC |
| 1383183--3/19/2008--CombiMatrix_Corp |
| 874733--9/13/2007--MEDIWARE_INFORMATION_SYSTEMS_INC |
| 1428156--3/10/2010--Celera_CORP |
| 313143--5/25/2007--HAEMONETICS_CORP |
| 1114529--3/16/2007--VIACELL_INC |
| 1279695--3/30/2009--UNIVERSAL_BIOSENSORS_INC |
| 1047188--3/16/2009--PENWEST_PHARMACEUTICALS_CO |
| 1145197--3/16/2009--INSULET_CORP |
|
| related topics |
| {product, candidate, development} |
| {product, liability, claim} |
| {cost, operation, labor} |
| {customer, product, revenue} |
| {capital, credit, financial} |
| {regulation, government, change} |
| {stock, price, operating} |
| {cost, contract, operation} |
| {interest, director, officer} |
| {operation, international, foreign} |
| {product, market, service} |
| {condition, economic, financial} |
| {cost, regulation, environmental} |
| {gas, price, oil} |
| {stock, price, share} |
| {system, service, information} |
| {property, intellectual, protect} |
| {operation, natural, condition} |
| {regulation, change, law} |
| {personnel, key, retain} |
|